A ‘WIN WIN’ FIBROMYALGIA CONFERENCE

News from the world of fibromyalgia. Leading speakers at SE England fibromyalgia conference share their insights into the brains of fibromites, sleep patterns and their diets.

Addition of Lyrica Significantly Improved Generalized Anxiety Disorder Symptoms in Patients Who Responded Only Partially to Previous GAD Treatments

From the FMS Global News Desk of Jeanne Hambleton (UK) First Large, Placebo-Controlled Study to Demonstrate Efficacy of Lyrica as Add-on Therapy Strategy in Difficult-to-Treat GAD Patients May 19, 2009 03:00 PM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–The addition of Pfizer’s Lyrica® (pregabalin) capsules CV to other generalized anxiety disorder (GAD) treatments significantly improved the [...]

FDA MedWatch – Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B): Boxed Warning required

From the FMS Global News Desk of Jeanne Hambleton (UK) Courtesy of FDA/Center for Drug Evaluation and Research FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen warnings in product labeling and add a boxed warning [...]

Fibromyalgia and Epilepsy Drug Lyrica Helps Restless Leg Sufferers, Researchers Say

From the FMS Global News Desk of Jeanne Hambleton (UK) Courtesy of attorneyatlaw.com Legal Briefs Lyrica, the Pfizer drug for treatment of the chronic pain disorder fibromyalgia and preventing epileptic seizures, also appears to benefit people who cannot get to sleep because of restless legs syndrome, new findings suggest. A recently completed clinical trial found [...]

Bottled Water: FAQ on Safety and Purity

From the FMS Global News Desk of Jeanne Hambleton (UK) Courtesy WebMD.com. Health and Cooking /em> By Salynn Boyles -Reviewed by Louise Chang, MD – WebMD Health News Americans drank 9 billion gallons of bottled water last year, or slightly more than 29 gallons for every man, woman, and child in the country. They also [...]

Alert: MedWatch – Digoxin (Caraco brand) – Recall of tablets because they may differ in size

Caraco Pharmaceutical Laboratories and FDA notified healthcare professionals of a consumer-level recall of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September, 2011. The tablets are being recalled because they may differ in size and [...]